Interactions between EBVgp350/220 and complement receptor type 2 (CR2)/CD21 and/or (CR1)/CD35 on B-cells is required for cellular attachment and initiation of latent infection [13-15]. The gene discussed is CR2; the disease is disease arising from reactivation of latent virus.